Momenta Pharmaceuticals, Inc. MNTA

Momenta Pharmaceuticals, Inc. 784 Memorial Drive 77 Massachusetts Avenue Cambridge, MA 02139
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1235010

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	3/29/2018	Court of Appeals for the Federal Circuit	18-1740	Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, ...	Plaintiff - Appellant
	5/24/2017	Delaware District Court	1:17-cv-00597	Teva Pharmaceuticals USA, Inc., et al v. Sandoz Inc.	Defendant
	2/2/2017	Delaware District Court	1:17-cv-00109	Momenta Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, I...	Plaintiff
	1/13/2017	New Jersey District Court	3:17-cv-00275	TEVA PHARMACEUTICALS USA, INC. et al v. SANDOZ INC. et al	Defendant
	12/19/2016	Delaware District Court	1:16-cv-01267	Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddys Labora...	Defendant
	1/26/2016	Massachusetts District Court	1:16-cv-10112	Amphastar Pharmaceuticals, Inc. et al v. Momenta Pharmaceuti...	Defendant
	1/26/2016	Massachusetts District Court	1:16-cv-10112	Amphastar Pharmaceuticals, Inc. et al v. Momenta Pharmaceuti...	Counter claimant
	10/14/2015	Tennessee Middle District Court	3:15-cv-01100	The Hospital Authority of Metropolitan Government of Nashvil...	Defendant
	9/17/2015	California Central District Court	5:15-cv-01914	Amphastar Pharmaceuticals, Inc. et al v. Momenta Pharmaceuti...	Defendant
	7/2/2015	USPTO Patent Trial and Appeal Board	IPR2015-01537	Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Compan...	Petitioner
	4/10/2015	Delaware District Court	1:15-cv-00306	Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Labor...	Defendant
	9/12/2014	New Jersey District Court	3:14-cv-05672	TEVA PHARMACEUTICALS USA, INC. et al v. DOCTOR REDDY'S LABOR...	Defendant
	9/10/2014	Delaware District Court	1:14-cv-01171	Teva Pharmaceuticals USA Inc. et al v. Sandoz Inc. et al.	Counter Claimant
	5/9/2014	District Of Columbia District Court	1:14-cv-00786	TEVA PHARMACEUTICAL INDUSTRIES, LTD. et al v. SEBELIUS et al	Intervenor-Defendant
	9/21/2011	Massachusetts District Court	1:11-cv-11681	Momenta Pharmaceuticals, Inc. et al v. Amphastar Pharmaceuti...	Plaintiff
	12/2/2010	Massachusetts District Court	1:10-cv-12079-NMG	Momenta Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals ...	Plaintiff
	12/2/2010	Massachusetts District Court	1:10-cv-12079-NMG	Momenta Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals ...	Counter Defendant
	12/10/2009	New York Southern District Court	1:09-cv-10112	Teva Pharmaceuticals USA, Inc. et al v. Sandoz Inc. et al	Defendant
	8/28/2008	New York Southern District Court	1:08-cv-07611-BSJ	Teva Pharmaceuticals USA, Inc. et al v. Sandoz, Inc. et al	Defendant
	8/28/2008	New York Southern District Court	1:08-cv-07611-BSJ	Teva Pharmaceuticals USA, Inc. et al v. Sandoz, Inc. et al	Counter-Claimant
	9/13/2004	USPTO Trademark Trial and Appeal Board	91162115-OPP	Momenta Pharmaceuticals, Inc. v. Nps Pharmaceuticals, Inc.	Plaintiff
	8/9/2004	USPTO Trademark Trial and Appeal Board	78235558-EXT	Momenta Pharmaceuticals, Inc. v. Nps Pharmaceuticals, Inc.	Potential Opposer

22 Rows Total

Inside Counsel (1)

Go Pro to view corporate inside counsel.

Outside Counsel (105)

	Last Name	First Name	Middle Name	Firm	Location
				Troutman Pepper Locke Llp	BERWYN, PA
	Aannestad	Anders	Tingulstad	Morrison & Foerster, LLP	TUCSON,
	Abraham	Eric	I.
	Aceto	Donato		Fish & Richardson, PC	MINNEAPOLIS, MN
	Alpha-cobb	Cambria	J.	Fish & Richardson, PC	MINNEAPOLIS, MN
	Anderson	Matthew	V.
	Arikat	Carmel	R	Axinn, Veltrop & Harkrider LLP
	Arikat	Carmel	R
	Becker	Matthew	J.	Axinn, Veltrop & Harkrider LLP	Hartford, CT
	Bell	Mark	R.		BERWYN, PA
	BEVILACQUA	MIHCAEL		Hale & Dorr LLP
	Bredrup	Julia	Jill	Caldwell Leslie & Proctor PC	Los Angeles, CA
	Bredrup	Julia	Jill
	Brill	Sophia	Madeleine	Morrison & Foerster, LLP
	Buchanan	Robert	M.	Choate Hall & Stewart, LLP
	Chen	Thomas	Chiunhong	Morrison & Foerster, LLP	San Diego, CA
	Coen	Kara	B.	Gibson Dunn & Crutcher, LLP
	Cooney	Patrick	Dermid	Fish & Richardson, PC	Wilmington, DE
	D'Amore	Matthew	Mark	Morrison & Foerster, LLP	New York, NY
	Dagen	Richard	B.	Axinn, Veltrop & Harkrider LLP
	Dagen	Richard	B.
	Doyle	David	C.	Morrison & Foerster, LLP	SAN DIEGO, CA
	Dray-Siegel	Anna	Rachel	Office of the Massachusetts Attorney General	Boston, MA
	Edgarton	G.	Mark	Choate Hall & Stewart, LLP
	Ehrich	Thomas	H.
	Fails	Greta		Choate Hall & Stewart, LLP	Boston, MA
	Fails	Greta	A.	Choate Hall & Stewart, LLP
	Fails	Greta	A.
	Forbes	Erin	M.
	Frank	Robert	S.	Choate Hall & Stewart, LLP	Ma,
	Frank	Robert	S.		Ma,
	Galligan	Christopher	P.
	Gattuso	Dominick	T.	Proctor Heyman LLP	Wilmington, DE
	Gattuso	Dominick	T.
	Gattuso	Dominick	T.	Suite 200	Wilmington, DE
	Gattuso	Dominick	T	Heyman Enerio Gattuso & Hirzel LLP
	Grimes	R.	Dale	Bass Berry & Sims, PLC	Nashville, TN
	Herschbach	Ph.d.	Brenda
	Hyma	Katie		Fish & Richardson, PC	MINNEAPOLIS, MN
	Hymn	Katie		Fish & Richardson, PC	MINNEAPOLIS, MN
	Jarrell	Brenda	Herschbach	Choate Hall & Stewart, LLP
	Jarrell	Brenda	Hershbach
	Jr	Robert	M Buchanan ,
	Justus	Bradley	D.	Axinn, Veltrop & Harkrider LLP	Washington, DC
	Justus	Bradley	D.
	Keeley	Michael	L.	Axinn, Veltrop & Harkrider LLP	Washington, DC
	Keeley	Michael	L.
	Khagi	Irene	Oberman	Choate Hall & Stewart, LLP	Boston, MA
	Khagi	Irene	Oberman		Raleigh, NC
	Kramer	Brian	Matthew	Morrison & Foerster, LLP	Ca,
	Kugler	Janice	L.	Fish & Richardson, PC	BOSTON, MA
	Kugler	Janiec	L.	Fish & Richardson, PC
	Lawrence	Laurie	Butler	Fish & Richardson, PC
	Lawrence	Laurie	Butler		Cambridge, MA
	Lee	Jessica	Gan	Choate Hall & Stewart, LLP	Boston , MA
	Liu	Xianxiao		Axinn, Veltrop & Harkrider LLP
	Liu	Xianxiao
	Lowe	Jeremy	C.	Axinn, Veltrop & Harkrider LLP
	Lowe	Jeremy	C.
	M.	Ph.d.	Anne		ITHACA, NY
	Marandett	Eric	J.	Choate Hall & Stewart, LLP	Boston, MA
	Matsui	Brian	R.	Morrison & Foerster, LLP
	Maynard	Deanne	E.	Morrison & Foerster, LLP
	Mazzochi	Deanne	M.		CHICAGO, IL
	Medina	Rolando		Choate Hall & Stewart, LLP	Boston, MA
	Meiklejohn	Anita	L.	Fish & Richardson, PC	MINNEAPOLIS, MN
	Meiklejohn	Anita			MINNEAPOLIS, MN
	Meiklejohn	Anita	L.		MINNEAPOLIS, MN
	Meiklejohn	Anita		Fish & Richardson, PC	MINNEAPOLIS, MN
	Milner	Clark	D.		Nashville, TN
	Murata	Jason	T.	Axinn, Veltrop & Harkrider LLP	Hartford, CT
	Murata	Jason	T.
	Murawski	Michael	E.	Choate Hall & Stewart, LLP	Boston , MA
	MYERS	LOUIS		Fish & Richardson, PC
	Nickson	Philip	B.	Fish & Richardson, PC	MINNEAPOLIS, MN
	Oakes	Daniel	K.	Axinn, Veltrop & Harkrider LLP	Washington, DC
	Oakes	Daniel	K.
	Olson	Erik	J.	Morrison & Foerster, LLP	Ca,
	Place	Two	International	Choate Hall & Stewart, LLP	BOSTON, MA
	Proctor	Michael	J.	Boies, Schiller & Flexner, LLP	Los Angeles, CA
	Proctor	Michael	J	Durie Tangri LLP
	Proctor	Michael	J
	Rakoczy	William	A.
	Reisberg	Joshua		Axinn, Veltrop & Harkrider LLP
	Roberts	Christopher	B.
	Rohback	Thomas	G.	Axinn, Veltrop & Harkrider LLP	Hartford, CT
	Rohback	Thomas	G.
	Saveriano	Christina	Lynn
	Schou	Courtney	M.	Choate Hall & Stewart, LLP	Boston , MA
	Scolnick	Daniel	M.	Troutman Pepper Hamilton Sanders Llp	BERWYN, PA
	Seol	Diane	C.	Choate Hall & Stewart, LLP	Boston, MA
	Seol	Diane		Choate Hall & Stewart, LLP
	Seol	Diane
	Siva	Varnitha		Axinn, Veltrop & Harkrider LLP
	Siva	Varnitha
	Street	One	Main	Lando & Anastasi, LLP	CAMBRIDGE, MA
	Tan	Anna	M.	Fish & Richardson, PC	MINNEAPOLIS, MN
	Tan	Anna			MINNEAPOLIS, MN
	Waldron	Rachel	P.
	Wang	Sophie	F.	Choate Hall & Stewart, LLP	Boston , MA

105 Rows Total	Page 1 of 2 | Go To

Filter By Form All Records 10-K 10-K/A 10-Q 10-Q/A 3 3/A 4 4/A 424B4 424B5 5 8-A12G 8-A12G/A 8-K 8-K/A ARS CORRESP CT ORDER DEF 14A DEFA14A DEFR14A EFFECT POSASR PRE 14A REGDEX S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A UPLOAD From To

	Date	Entity	Form Number	Description
	11/10/2020		SC 13G/A
	10/13/2020		15-12G
	10/1/2020		SC TO-T/A
	10/1/2020		SC 14D9/A
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		S-8 POS
	10/1/2020		POSASR
	10/1/2020		8-K	Current report pursuant to Section 13 or 15(d)
	10/1/2020	Stoner, Elizabeth	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Guiterrez-Ramos Jose Carlos	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Grogan, Donna Roy	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Gilman, Steven C.	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Gemayel Georges	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Downey Bruce	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Barlow Jane F	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Manning, Anthony M.	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Kwon, Young	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Fier, Ian	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Cieplinska Agnieszka	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Carvajal Alejandra	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Beltramello Jo Ann	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Arroyo Santiago	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Wheeler Craig A	4	Statement of changes in beneficial ownership of securities
	10/1/2020		25-NSE
	9/23/2020		SC TO-T/A
	9/23/2020		SC 14D9/A
	9/15/2020		SC TO-T/A
	9/15/2020		SC 14D9/A
	9/4/2020		SC TO-T/A
	9/4/2020		SC 14D9/A
	9/2/2020		SC TO-T
	9/2/2020		SC 14D9
	8/21/2020	Fier, Ian	4	Statement of changes in beneficial ownership of securities
	8/20/2020		SC TO-C
	8/20/2020	Guiterrez-Ramos Jose Carlos	4	Statement of changes in beneficial ownership of securities
	8/19/2020		SC14D9C
	8/19/2020		SC TO-C
	8/19/2020		8-K	Current report pursuant to Section 13 or 15(d)

1,983 Rows Total	Page 1 of 40 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	4/14/2025	Zang, Ru	Assignor	Application Publication	17419480 20220033487	Methods of Producing Ustekinumab Methods of Producing Ustekinumab
	1/13/2025	Prentice, Holly	Assignor	Application Publication	18917427 20250115940	Cell Culture Process Cell Culture Process
	7/1/2024	Huston, James S.	Assignor	Application Publication	18753820 20250011432	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	7/1/2024	Ling, Leona E.	Assignor	Application Publication	18753820 20250011432	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	7/1/2024	Bosques, Carlos J.	Assignor	Application Publication	18753820 20250011432	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	7/1/2024	Lansing, Jonathan C.	Assignor	Application Publication	18753820 20250011432	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	7/1/2024	Meador, James, Iii	Assignor	Application Publication	18753820 20250011432	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	7/1/2024	Rutitzky, Laura	Assignor	Application Publication	18753820 20250011432	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	7/1/2024	Ortiz, Daniel	Assignor	Application Publication	18753820 20250011432	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	1/30/2024	Prentice, Holly	Assignor	Application Publication Patent	17032806 20210246477 12139735	Cell Culture Process Cell Culture Process Cell Culture Process
	9/12/2023	Janssen Research & Development, LLC	Assignor	Application Publication	18258189 20240317865	Antibodies Against Integrin Alpha 11 Beta 1 Antibodies Against Integrin Alpha 11 Beta 1
	8/10/2023	Patil, Siddhesh	Assignor	Application Publication	18022069 20230365713	Sialylated Glycoproteins Sialylated Glycoproteins
	5/11/2023	King, David J.	Assignor	Application Publication	16825066 20200299382	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	5/11/2023	Kehry, Marilyn	Assignor	Application Publication	16825066 20200299382	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	5/11/2023	Manning, Anthony	Assignor	Application Publication	16825066 20200299382	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	5/11/2023	Ling, Leona E.	Assignor	Application Publication	16825066 20200299382	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	5/11/2023	Roy, Sucharita	Assignor	Application Publication	16825066 20200299382	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	5/11/2023	Meador, James, Iii	Assignor	Application Publication	16825066 20200299382	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	3/23/2023	Ling, Leona	Assignor	Application Publication	18187421 20230221302	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Capila, Ishan	Assignor	Application Publication	18187421 20230221302	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Mcconnell, Kevin	Assignor	Application Publication	18187421 20230221302	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Farutin, Victor	Assignor	Application Publication	18187421 20230221302	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Prod'homme, Thomas	Assignor	Application Publication	18187421 20230221302	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Ling, Leona	Assignor	Application Publication Patent	18187421 20230221302 12163951	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Capila, Ishan	Assignor	Application Publication Patent	18187421 20230221302 12163951	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Mcconnell, Kevin	Assignor	Application Publication Patent	18187421 20230221302 12163951	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Farutin, Victor	Assignor	Application Publication Patent	18187421 20230221302 12163951	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	3/23/2023	Prod'homme, Thomas	Assignor	Application Publication Patent	18187421 20230221302 12163951	Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment Methods For Predicting Response To Treatment
	2/2/2023	Janssen Biotech, Inc.	Assignee	Application Application Application Application Publication Publication Publication Publication Patent Patent Patent Patent	13829333 14941984 14131005 14149931 20140274912 20160068881 20140142286 20140120583 9217168 9663810 9475858 8852889	Cell Culture Process Cell Culture Process Methods Of Cell Culture Methods Of Cell Culture Cell Culture Process Cell Culture Process Methods Of Cell Culture Methods Of Cell Culture Cell Culture Process Cell Culture Process Methods Of Cell Culture Methods Of Cell Culture
	12/28/2022	Dilafor Ab	Assignee	Application Application Application Application Publication Publication Publication Publication Patent Patent Patent Patent	12816369 14039801 14039811 12762268 20100324276 20100316640 20140031315 20140024602 8592393 8569262 9212233 9358252	Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre... Polysaccharide Compositions And Methods Of Use For The Treatment And Pre...
	10/26/2022	Bhatnagar, Naveen	Assignor	Application Publication	17909282 20230374062	Methods Of Making Hyper-sialylated Immunoglobulin Methods Of Making Hyper-sialylated Immunoglobulin
	10/26/2022	Meador, James, Iii	Assignor	Application Publication	17909282 20230374062	Methods Of Making Hyper-sialylated Immunoglobulin Methods Of Making Hyper-sialylated Immunoglobulin
	9/26/2022	Manning, Anthony	Assignor	Application Publication	17739912 20220267413	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Ling, Leona E.	Assignor	Application Publication	17739912 20220267413	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Bosques, Carlos J.	Assignor	Application Publication	17739912 20220267413	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Kaundinya, Ganesh	Assignor	Application Publication	17739912 20220267413	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Prod'homme, Thomas E.	Assignor	Application Publication	17739912 20220267413	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Manning, Anthony	Assignor	Application Publication Patent	17739912 20220267413 12297256	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Ling, Leona E.	Assignor	Application Publication Patent	17739912 20220267413 12297256	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Bosques, Carlos J.	Assignor	Application Publication Patent	17739912 20220267413 12297256	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Kaundinya, Ganesh	Assignor	Application Publication Patent	17739912 20220267413 12297256	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/26/2022	Prod'homme, Thomas E.	Assignor	Application Publication Patent	17739912 20220267413 12297256	Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration Methods For The Treatment Of Neurodegeneration
	9/9/2022	Meador, James, Iii	Assignor	Application Publication	17802441 20230303984	Enzymes for Sialylation of Glycans Enzymes for Sialylation of Glycans
	9/9/2022	Sipsey, Sandra Freitas Pavao	Assignor	Application Publication	17802441 20230303984	Enzymes for Sialylation of Glycans Enzymes for Sialylation of Glycans
	9/9/2022	Medeiros, Amy	Assignor	Application Publication	17802441 20230303984	Enzymes for Sialylation of Glycans Enzymes for Sialylation of Glycans
	9/9/2022	Gurnani, Srishti	Assignor	Application Publication	17802441 20230303984	Enzymes for Sialylation of Glycans Enzymes for Sialylation of Glycans
	9/9/2022	Meador, James, Iii	Assignor	Application Publication	17802441 20230303984	Enzymes for Sialylation of Glycans Enzymes for Sialylation of Glycans
	9/9/2022	Sipsey, Sandra Freitas Pavao	Assignor	Application Publication	17802441 20230303984	Enzymes for Sialylation of Glycans Enzymes for Sialylation of Glycans
	9/9/2022	Medeiros, Amy	Assignor	Application Publication	17802441 20230303984	Enzymes for Sialylation of Glycans Enzymes for Sialylation of Glycans
	9/9/2022	Gurnani, Srishti	Assignor	Application Publication	17802441 20230303984	Enzymes for Sialylation of Glycans Enzymes for Sialylation of Glycans
	8/16/2022	Meador, James, Iii	Assignor	Application Publication	17802441 20230303984
	8/16/2022	Medeiros, Amy	Assignor	Application Publication	17802441 20230303984
	8/16/2022	Gurnani, Srishti	Assignor	Application Publication	17802441 20230303984
	8/16/2022	Sipsey, Sandy	Assignor	Application Publication	17802441 20230303984
	8/15/2022	Meador, James, Iii	Assignor	Application Publication	17757607 20230050972	Antibodies Against Integrin Alpha 11 Beta 1 Antibodies Against Integrin Alpha 11 Beta 1
	8/15/2022	Kurtagic, Elma	Assignor	Application Publication	17757607 20230050972	Antibodies Against Integrin Alpha 11 Beta 1 Antibodies Against Integrin Alpha 11 Beta 1
	8/15/2022	Beneduce, Christopher, Jr	Assignor	Application Publication	17757607 20230050972	Antibodies Against Integrin Alpha 11 Beta 1 Antibodies Against Integrin Alpha 11 Beta 1
	8/15/2022	Meador, James, Iii	Assignor	Application Publication	17757607 20230050972	Antibodies Against Integrin Alpha 11 Beta 1 Antibodies Against Integrin Alpha 11 Beta 1
	8/15/2022	Kurtagic, Elma	Assignor	Application Publication	17757607 20230050972	Antibodies Against Integrin Alpha 11 Beta 1 Antibodies Against Integrin Alpha 11 Beta 1
	8/15/2022	Beneduce, Christopher, Jr	Assignor	Application Publication	17757607 20230050972	Antibodies Against Integrin Alpha 11 Beta 1 Antibodies Against Integrin Alpha 11 Beta 1
	5/11/2022	Bosques, Carlos J.	Assignor	Application Publication	17491677 20220049019	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Washburn, Nathaniel J.	Assignor	Application Publication	17491677 20220049019	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Lansing, Jonathan C.	Assignor	Application Publication	17491677 20220049019	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Rutitzky, Laura	Assignor	Application Publication	17491677 20220049019	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Ortiz, Daniel	Assignor	Application Publication	17491677 20220049019	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Bosques, Carlos J.	Assignor	Application Publication Application	17491677 20220049019 12297291	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Washburn, Nathaniel J.	Assignor	Application Publication Application	17491677 20220049019 12297291	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Lansing, Jonathan C.	Assignor	Application Publication Application	17491677 20220049019 12297291	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Rutitzky, Laura	Assignor	Application Publication Application	17491677 20220049019 12297291	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	5/11/2022	Ortiz, Daniel	Assignor	Application Publication Application	17491677 20220049019 12297291	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	4/28/2022	King, David J.	Assignor	Application Publication	17661070 20230049725	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	4/28/2022	Kehry, Marilyn	Assignor	Application Publication	17661070 20230049725	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	4/28/2022	Manning, Anthony	Assignor	Application Publication	17661070 20230049725	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	4/28/2022	Roy, Sucharita	Assignor	Application Publication	17661070 20230049725	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	4/28/2022	Washburn, Nathaniel	Assignor	Application Publication	17661070 20230049725	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	4/28/2022	Meador, James, Iii	Assignor	Application Publication	17661070 20230049725	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	4/28/2022	Hillson, Jan	Assignor	Application Publication	17661070 20230049725	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	4/28/2022	Leona E. Ling	Assignor	Application Publication	17661070 20230049725	FcRn Antibodies and Methods of Use Thereof FcRn Antibodies and Methods of Use Thereof
	4/15/2022	Bosques, Carlos J.	Assignor	Application Publication	17508026 20220056109	Glycoproteins With Anti-inflammatory Properties Glycoproteins With Anti-inflammatory Properties
	4/15/2022	Washburn, Nathaniel J.	Assignor	Application Publication	17508026 20220056109	Glycoproteins With Anti-inflammatory Properties Glycoproteins With Anti-inflammatory Properties
	4/15/2022	Sarvaiya, Hetal	Assignor	Application Publication	17508026 20220056109	Glycoproteins With Anti-inflammatory Properties Glycoproteins With Anti-inflammatory Properties
	4/15/2022	Arevalo, Enrique	Assignor	Application Publication	17508026 20220056109	Glycoproteins With Anti-inflammatory Properties Glycoproteins With Anti-inflammatory Properties
	4/15/2022	Bosques, Carlos J.	Assignor	Application Publication Patent	17527741 20220267388 11827682	ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS
	4/15/2022	Lansing, Jonathan C.	Assignor	Application Publication Patent	17527741 20220267388 11827682	ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS
	4/15/2022	Ortiz, Daniel	Assignor	Application Publication Patent	17527741 20220267388 11827682	ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS
	3/11/2022	Janssen Biotech, Inc.	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication ...and 31 more	17508026 16671595 15141413 17259051 16589634 15028917 14416869 16303831 17100428 17403278 14890865 15985288 17259491 17032994 16474640 15957703 16303793 14787403 17491677 15954146 16363846 16688772 17259067 17407814 17033452 17284188 20160090409 ...and 31 more	Sialylated Glycoproteins Treatment With Highly Silylated Igg Compositions COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Compositions And Methods Related To Engineered Fc-antigen Binding Domain... Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Treatment With Highly Silylated Igg Compositions COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Compositions and Methods Related to Engineered Fc Constructs COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... Sialylated Glycoproteins ...and 31 more
	3/11/2022	Janssen Biotech, Inc.	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 41 more	15141413 17100428 17508026 16363846 17284188 17259051 17407814 15954146 17527741 17032994 14416869 15028917 14787403 17403278 17259491 16303831 16589634 16303793 17491677 17033452 15957703 16474640 16671595 16081829 14890865 17259067 15985288 ...and 41 more	Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Compositions And Methods Related To Engineered Fc-antigen Binding Domain... METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Methods For The Treatment Of Neurodegeneration Treatment With Highly Silylated Igg Compositions COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Compositions and Methods Related to Engineered Fc Constructs COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins ...and 41 more
	3/11/2022	Janssen Biotech, Inc.	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 42 more	17033452 15957703 17491677 16474640 16671595 16081829 14890865 17259067 15985288 17602156 16688772 17100428 17508026 15141413 17284188 17259051 15954146 17527741 17032994 14416869 15028917 14787403 17403278 16363846 17259491 17407814 16589634 ...and 42 more	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Methods for Measuring Consumption of Amino Acid N-Carboxyanhydrides duri... Sialylated Glycoproteins Compositions and Methods Related to Engineered Fc Constructs COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS ...and 42 more
	3/11/2022	Janssen Biotech, Inc.	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 43 more	14787403 17403278 17259491 16589634 17033452 15957703 16474640 16363846 16671595 16081829 17407814 14890865 17259067 16303831 15985288 17602156 16303793 16688772 17491677 17100428 17508026 15141413 17284188 17259051 15954146 17527741 17032994 ...and 43 more	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Compositions And Methods Related To Engineered Fc-antigen Binding Domain... Methods for Measuring Consumption of Amino Acid N-Carboxyanhydrides duri... Sialylated Glycoproteins Treatment With Highly Silylated Igg Compositions COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties ...and 43 more
	11/30/2021	Janssen Biotech, Inc.	Assignee	Application Publication	17259491 20210269546	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	11/4/2021	Janssen Biotech, Inc.	Assignee	Application Publication	17403278 20220025115	Methods for Measuring Consumption of Amino Acid N-Carboxyanhydrides duri... Methods for Measuring Consumption of Amino Acid N-Carboxyanhydrides duri...
	10/15/2021	Huston, James S.	Assignor	Application Publication	17407814 20220033499	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Ling, Leona E.	Assignor	Application Publication	17407814 20220033499	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Bosques, Carlos J.	Assignor	Application Publication	17407814 20220033499	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Lansing, Jonathan C.	Assignor	Application Publication	17407814 20220033499	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Meador, James, Iii	Assignor	Application Publication	17407814 20220033499	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Rutitzky, Laura	Assignor	Application Publication	17407814 20220033499	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Ortiz, Daniel	Assignor	Application Publication	17407814 20220033499	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Huston, James S.	Assignor	Application Publication Patent	17407814 20220033499 12071482	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Ling, Leona E.	Assignor	Application Publication Patent	17407814 20220033499 12071482	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Bosques, Carlos J.	Assignor	Application Publication Patent	17407814 20220033499 12071482	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Lansing, Jonathan C.	Assignor	Application Publication Patent	17407814 20220033499 12071482	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Meador, James, Iii	Assignor	Application Publication Patent	17407814 20220033499 12071482	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Rutitzky, Laura	Assignor	Application Publication Patent	17407814 20220033499 12071482	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/15/2021	Ortiz, Daniel	Assignor	Application Publication Patent	17407814 20220033499 12071482	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	10/12/2021	Iyer, Mani	Assignor	Application Publication	17403278 20220025115	Methods for Measuring Consumption of Amino Acid N-Carboxyanhydrides duri... Methods for Measuring Consumption of Amino Acid N-Carboxyanhydrides duri...
	8/19/2021	Manning, Anthony	Assignor	Application Publication	17259067 20210147549	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	8/19/2021	Lansing, Jonathan C.	Assignor	Application Publication	17259067 20210147549	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	8/19/2021	Rutitzky, Laura	Assignor	Application Publication	17259067 20210147549	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	8/19/2021	Ortiz, Daniel	Assignor	Application Publication	17259067 20210147549	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	8/19/2021	Janssen Biotech, Inc.	Assignee	Application Publication	17259067 20210147549	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	8/19/2021	Janssen Biotech, Inc.	Assignee	Application Publication	17259051 20210284717	Compositions And Methods Related To Engineered Fc-antigen Binding Domain... Compositions And Methods Related To Engineered Fc-antigen Binding Domain...
	8/19/2021	Lansing, Jonathan C.	Assignor	Application Publication	17259051 20210284717	Compositions And Methods Related To Engineered Fc-antigen Binding Domain... Compositions And Methods Related To Engineered Fc-antigen Binding Domain...
	8/19/2021	Ortiz, Daniel	Assignor	Application Publication	17259051 20210284717	Compositions And Methods Related To Engineered Fc-antigen Binding Domain... Compositions And Methods Related To Engineered Fc-antigen Binding Domain...
	8/6/2021	Bosques, Carlos J.	Assignor	Application Publication	16303793 20190284305	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Washburn, Nathaniel	Assignor	Application Publication	16303793 20190284305	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Lansing, Jonathan C.	Assignor	Application Publication	16303793 20190284305	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Rutitzky, Laura	Assignor	Application Publication	16303793 20190284305	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Ortiz, Daniel	Assignor	Application Publication	16303793 20190284305	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Bosques, Carlos J.	Assignor	Application Publication Patent	16303793 20190284305 11155640	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Washburn, Nathaniel	Assignor	Application Publication Patent	16303793 20190284305 11155640	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Lansing, Jonathan C.	Assignor	Application Publication Patent	16303793 20190284305 11155640	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Rutitzky, Laura	Assignor	Application Publication Patent	16303793 20190284305 11155640	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	8/6/2021	Ortiz, Daniel	Assignor	Application Publication Patent	16303793 20190284305 11155640	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
	7/15/2021	Singh, Narinder	Assignor	Application Application Publication Publication	17260318 17260318 20210299255 20210299255	Compositions Of Fcrn Antibodies And Methods Of Use Thereof Compositions Of Fcrn Antibodies And Methods Of Use Thereof
	7/15/2021	St. Louis, Gregory	Assignor	Application Application Publication Publication	17260318 17260318 20210299255 20210299255	Compositions Of Fcrn Antibodies And Methods Of Use Thereof Compositions Of Fcrn Antibodies And Methods Of Use Thereof
	7/15/2021	Zhang, Zhongli	Assignor	Application Application Publication Publication	17260318 17260318 20210299255 20210299255	Compositions Of Fcrn Antibodies And Methods Of Use Thereof Compositions Of Fcrn Antibodies And Methods Of Use Thereof
	7/15/2021	Williams, Eva	Assignor	Application Application Publication Publication	17260318 17260318 20210299255 20210299255	Compositions Of Fcrn Antibodies And Methods Of Use Thereof Compositions Of Fcrn Antibodies And Methods Of Use Thereof
	7/15/2021	Patil, Siddhesh	Assignor	Application Application Publication Publication	17260318 17260318 20210299255 20210299255	Compositions Of Fcrn Antibodies And Methods Of Use Thereof Compositions Of Fcrn Antibodies And Methods Of Use Thereof
	7/7/2021	Janssen Biotech, Inc.	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication ...and 27 more	14787403 16474640 14416869 15954146 15028917 16688772 17033452 16303831 16303793 16671595 15957703 14787403 16589634 15028917 17100428 16303793 16474640 14890865 14416869 14890865 15985288 15141413 17032994 16363846 16303831 20190284305 20200055921 ...and 27 more	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration Glycoproteins With Anti-inflammatory Properties Methods For The Treatment Of Neurodegeneration Glycoproteins With Anti-inflammatory Properties Compositions and Methods Related to Engineered Fc Constructs Sialylated Glycoproteins Compositions and Methods Related to Engineered Fc Constructs COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration Glycoproteins With Anti-inflammatory Properties Methods For The Treatment Of Neurodegeneration ...and 25 more
	7/7/2021	Janssen Biotech, Inc.	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication ...and 28 more	15028917 17100428 16303793 16474640 14890865 14416869 14890865 15985288 17032994 16303831 14787403 16474640 14416869 15954146 15141413 15028917 16688772 16363846 17033452 16303831 16303793 16671595 15957703 14787403 16589634 20210040527 20210221917 ...and 28 more	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration Glycoproteins With Anti-inflammatory Properties Methods For The Treatment Of Neurodegeneration Sialylated Glycoproteins Glycoproteins With Anti-inflammatory Properties Methods For The Treatment Of Neurodegeneration Compositions and Methods Related to Engineered Fc Constructs COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration Sialylated Glycoproteins Glycoproteins With Anti-inflammatory Properties Methods For The Treatment Of Neurodegeneration Glycoproteins With Anti-inflammatory Properties ...and 28 more
	7/7/2021	Janssen Biotech, Inc.	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication ...and 30 more	15141413 16363846 14890865 16589634 16303831 15028917 17100428 14416869 14890865 14416869 15985288 15028917 17032994 16303793 16303831 16474640 14787403 14787403 15954146 16688772 17033452 16303793 15957703 16474640 16671595 20150210753 20160090409 ...and 30 more	Methods For The Treatment Of Neurodegeneration Compositions and Methods Related to Engineered Fc Constructs Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Methods For The Treatment Of Neurodegeneration Compositions and Methods Related to Engineered Fc Constructs Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Compositions and Methods Related to Engineered Fc Constructs Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins ...and 30 more
	7/7/2021	Janssen Biotech, Inc.	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 34 more	14890865 17032994 16303793 17284188 16474640 14787403 15954146 14416869 16688772 15028917 17033452 16303831 15957703 16671595 15141413 16363846 14787403 16589634 16303831 15028917 17284188 17100428 16303793 14416869 16474640 14890865 15985288 ...and 34 more	Sialylated Glycoproteins Glycoproteins With Anti-inflammatory Properties COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration Compositions and Methods Related to Engineered Fc Constructs Glycoproteins With Anti-inflammatory Properties Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Compositions and Methods Related to Engineered Fc Constructs Sialylated Glycoproteins Treatment With Highly Silylated Igg Compositions Treatment With Highly Silylated Igg Compositions COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Methods For The Treatment Of Neurodegeneration Compositions and Methods Related to Engineered Fc Constructs COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Methods For The Treatment Of Neurodegeneration ...and 34 more
	7/7/2021	Janssen Biotech, Inc.	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 36 more	17100428 16303793 16474640 14890865 14416869 15141413 14416869 15985288 16363846 17032994 16303831 15028917 17284188 14787403 15954146 14787403 16688772 17033452 16303793 17284188 16303831 16474640 16671595 15957703 16589634 14890865 15028917 ...and 36 more	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Glycoproteins With Anti-inflammatory Properties COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Glycoproteins With Anti-inflammatory Properties Methods For The Treatment Of Neurodegeneration Compositions and Methods Related to Engineered Fc Constructs Glycoproteins With Anti-inflammatory Properties Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Compositions and Methods Related to Engineered Fc Constructs Sialylated Glycoproteins COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Treatment With Highly Silylated Igg Compositions COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Methods For The Treatment Of Neurodegeneration COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS Sialylated Glycoproteins Sialylated Glycoproteins Sialylated Glycoproteins ...and 36 more
	5/26/2021	Denney, William	Assignor	Application Publication	17284188 20210353752	Treatment With Highly Silylated Igg Compositions Treatment With Highly Silylated Igg Compositions
	5/26/2021	Arroyo, Santiago	Assignor	Application Publication	17284188 20210353752	Treatment With Highly Silylated Igg Compositions Treatment With Highly Silylated Igg Compositions
	3/5/2021	Gupta, Abhinav	Assignor	Application Publication	17259498 20210238310	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	3/5/2021	Lansing, Jonathan C.	Assignor	Application Publication	17259498 20210238310	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	3/5/2021	Ortiz, Daniel	Assignor	Application Publication	17259498 20210238310	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	2/26/2021	Lansing, Jonathan C.	Assignor	Application Publication	17259051 20210284717	Compositions And Methods Related To Engineered Fc-antigen Binding Domain... Compositions And Methods Related To Engineered Fc-antigen Binding Domain...
	2/26/2021	Ortiz, Daniel	Assignor	Application Publication	17259051 20210284717	Compositions And Methods Related To Engineered Fc-antigen Binding Domain... Compositions And Methods Related To Engineered Fc-antigen Binding Domain...
	2/26/2021	Manning, Anthony	Assignor	Application Publication	17259271 20220064298	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	2/26/2021	Lansing, Jonathan C.	Assignor	Application Publication	17259271 20220064298	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	2/26/2021	Rutitzky, Laura	Assignor	Application Publication	17259271 20220064298	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	2/26/2021	Ortiz, Daniel	Assignor	Application Publication	17259271 20220064298	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	2/17/2021	Manning, Anthony	Assignor	Application Publication	17259067 20210147549	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	2/17/2021	Lansing, Jonathan C.	Assignor	Application Publication	17259067 20210147549	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...
	2/17/2021	Ortiz, Daniel	Assignor	Application Publication	17259067 20210147549	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN... COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN...

148 Rows Total

	Date Recorded	Party	Role	Document Type	Document No.	Image
	10/14/2003	Mimeon, Inc.	Assignor	Application	78144322
	10/14/2003	Mimeon, Inc.	Assignor	Trademark	0
	10/14/2003	Mimeon, Inc.	Assignor	Application	78144337
	10/14/2003	Mimeon, Inc.	Assignor	Trademark	3275985
	10/14/2003	Mimeon, Inc.	Assignor	Application	78144319
	10/14/2003	Mimeon, Inc.	Assignor	Trademark	2863623
	10/14/2003	Mimeon, Inc.	Assignor	Application	78144312
	10/14/2003	Mimeon, Inc.	Assignor	Trademark	0
	1/2/2003	Mimeon, Inc.	Assignor	Trademark	0
	1/2/2003	Mimeon, Inc.	Assignor	Application	78088176

10 Rows Total